Sano Takeshi 佐野武

… Alternative Names

佐野武サノタケシ

SANO Talesjo 佐野武

Less

Researcher Number	30215884
Affiliation (Current)	2025: 公益財団法人がん研究会, 有明病院, 病院長
Affiliation (based on the past Project Information) *help	2019 – 2021: 公益財団法人がん研究会, 有明病院, 病院長 2017: 公益財団法人がん研究会, 有明病院, 副院長 1992 – 1993: 東京大学, 医学部(病), 助手
Review Section/Research Field	Except Principal Investigator Basic Section 55020:Digestive surgery-related / Digestive surgery / Digestive surgery
Keywords	Except Principal Investigator 胃癌 / abscopal effect / 免疫チェックポイント阻害薬 / 放射線療法 / 幹細胞 / 胃がん / 免疫 / がん幹細胞 / 放射線 / 癌幹細胞 … More / Gastric Cancer / Heterogeneity / 治療効果予測因子 / トラスツズマブ / HER2 heterigeneity / Biomarker / Trastuzumab / HER2 heterogeneity / Gastric cancer / HER2 / Interferon-gamma / Interleukin-2 / Anti-CD3 antibody / Adoptive immunotherapy / CD-8 / Cytotoxicity / Tumor-draining lymphnode / CDー3 / ILー2 / 抗CD-3抗体 / IL-2 / 腫瘍免疫 / CTL / T細胞 / サイトカイン / インターフェロンガンマ / インターロイキン2 / 細胞障害性試験 / 養子免疫 / tumor draining / interferon-γ / Interleukin2 / 抗CD3抗体 / 養子免疫療法 / CD8 / 細胞障害性 / 腫瘍灌流リンパ節 Less

Changes in the immunological profile of gastric cancer stem cells due to irradiation
- Principal Investigator
  
  KUMAGAI Koshi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Japanese Foundation for Cancer Research
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab eficacy
- Principal Investigator
  
  Wakatsuki Takeru
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  Japanese Foundation for Cancer Research
Analysis of the T-cells for the specific adoptive immunotherapy.
- Principal Investigator
  
  MASAKI Tadahiko, 酒井敬介
- Project Period (FY)
  1991 – 1993
- Research Category
  
  Grant-in-Aid for General Scientific Research (C)
- Research Field
  
  Digestive surgery
- Research Institution
  University of Tokyo

All 2020 2019 2018

All Journal Article

[Journal Article] ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.2020
- Author(s)
  Kawakami R, Mashima T, Kawata N, Kumagai K, Migita T, Sano T, Mizunuma N, Yamaguchi K, Seimiya H
- Journal Title
  
  Cancer Sci
  
  Volume: 111 Issue: 3 Pages: 962-973
- DOI
  10.1111/cas.14316
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07337, KAKENHI-PROJECT-19K09136, KAKENHI-PUBLICLY-18H04633, KAKENHI-PROJECT-19H03523, KAKENHI-PROJECT-16H06276
[Journal Article] In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.2019
- Author(s)
  Mashima T, Iwasaki R, Kawata N, Kawakami R, Kumagai K, Migita T, Sano T, Yamaguchi K, Seimiya H
- Journal Title
  
  Br J Cancer
  
  Volume: 121 Issue: 10 Pages: 846-856
- DOI
  10.1038/s41416-019-0600-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07337, KAKENHI-PROJECT-19K09136, KAKENHI-PUBLICLY-18H04633, KAKENHI-PROJECT-19H03523, KAKENHI-PROJECT-16H06276
[Journal Article] Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer2018
- Author(s)
  Wakatsuki Takeru、Yamamoto Noriko、Sano Takeshi、Chin Keisho、Kawachi Hiroshi、Takahari Daisuke、Ogura Mariko、Ichimura Takashi、Nakayama Izuma、Osumi Hiroki、Matsushima Tomohiro、Suenaga Mitsukuni、Shinozaki Eiji、Hiki Naoki、Ishikawa Yuichi、Yamaguchi Kensei
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 印刷中 Issue: 11 Pages: 1186-1195
- DOI
  10.1007/s00535-018-1464-0
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10123

1. Wakatsuki Takeru (60443876)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
2. Mashima Tetsuo (30311228)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
3. MASAKI Tadahiko (30238894)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. NAGAWA Hirokazu (80228064)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. KOBORI Ouichiro (30110696)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. Yamamoto Noriko (10280629)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
7. Mori Seiichi (10334814)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. KUMAGAI Koshi (40383848)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 酒井敬介 (40186987)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 山口研成 (10321845)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. MUTO Yasuhiko

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Sano Takeshi 佐野武

佐野武サノタケシ

SANO Talesjo 佐野武

Research Projects

Research Products

Co-Researchers

Changes in the immunological profile of gastric cancer stem cells due to irradiation

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab eficacy

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of the T-cells for the specific adoptive immunotherapy.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer2018

Author(s)

Journal Title

DOI

Data Source

Sano Takeshi 佐野 武

佐野 武 サノ タケシ

SANO Talesjo 佐野 武

Research Projects

Research Products

Co-Researchers

Changes in the immunological profile of gastric cancer stem cells due to irradiation

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Clinical impact of intratumoral HER2 heterogeneity on trastuzumab eficacy

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of the T-cells for the specific adoptive immunotherapy.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer2018

Author(s)

Journal Title

DOI

Data Source

Sano Takeshi 佐野武

佐野武サノタケシ

SANO Talesjo 佐野武